Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Chemotherapy
|
August 30, 2014
Experience with trabectedin in an advanced sarcoma patient on peritoneal dialysis for end-stage renal failure
Maung Maung Myat Moe, Carlos Fernandez Teruel, Arturo Soto-Matos
Cancer Chemotherapy and Pharmacology
|
June 22, 2015
Population pharmacokinetics of kahalalide F in advanced cancer patients
Bernardo Miguel-Lillo, Belén Valenzuela, José Esteban Peris-Ribera, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2008
Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects
Ricardo Nalda-Molina, Belén Valenzuela, Amelia Ramon-Lopez, et al.
Investigational New Drugs
|
July 13, 2010
Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas
Ramón Salazar, Ruth Plummer, Ana Oaknin, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2011
Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients
Carlos Pérez-Ruixo, Belén Valenzuela, Carlos Fernández Teruel, et al.
Clinical Pharmacokinetics
|
October 12, 2012
Population pharmacokinetic-pharmacodynamic analysis of neutropenia in cancer patients receiving PM00104 (Zalypsis(®))
Mario González-Sales, Belén Valenzuela, Carlos Pérez-Ruixo, et al.
Clinical Pharmacokinetics
|
September 15, 2007
Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients
Juan Jose Perez-Ruixo, Peter Zannikos, Sarapee Hirankarn, et al.
Cancer Chemotherapy and Pharmacology
|
March 19, 2011
Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis
Claudia Lebedinsky, Javier Gómez, Youn C Park, et al.
Marine Drugs
|
July 13, 2011
Plitidepsin has a safe cardiac profile: a comprehensive analysis
Arturo Soto-Matos, Sergio Szyldergemajn, Sonia Extremera, et al.
Cancer Chemotherapy and Pharmacology
|
October 9, 2007
Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment
Gerald J Fetterly, Joel S Owen, Kim Stuyckens, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Chemotherapy
|
August 30, 2014
Experience with trabectedin in an advanced sarcoma patient on peritoneal dialysis for end-stage renal failure
Maung Maung Myat Moe, Carlos Fernandez Teruel, Arturo Soto-Matos
Cancer Chemotherapy and Pharmacology
|
June 22, 2015
Population pharmacokinetics of kahalalide F in advanced cancer patients
Bernardo Miguel-Lillo, Belén Valenzuela, José Esteban Peris-Ribera, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2008
Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects
Ricardo Nalda-Molina, Belén Valenzuela, Amelia Ramon-Lopez, et al.
Investigational New Drugs
|
July 13, 2010
Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas
Ramón Salazar, Ruth Plummer, Ana Oaknin, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2011
Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients
Carlos Pérez-Ruixo, Belén Valenzuela, Carlos Fernández Teruel, et al.
Clinical Pharmacokinetics
|
October 12, 2012
Population pharmacokinetic-pharmacodynamic analysis of neutropenia in cancer patients receiving PM00104 (Zalypsis(®))
Mario González-Sales, Belén Valenzuela, Carlos Pérez-Ruixo, et al.
Clinical Pharmacokinetics
|
September 15, 2007
Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients
Juan Jose Perez-Ruixo, Peter Zannikos, Sarapee Hirankarn, et al.
Cancer Chemotherapy and Pharmacology
|
March 19, 2011
Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis
Claudia Lebedinsky, Javier Gómez, Youn C Park, et al.
Marine Drugs
|
July 13, 2011
Plitidepsin has a safe cardiac profile: a comprehensive analysis
Arturo Soto-Matos, Sergio Szyldergemajn, Sonia Extremera, et al.
Cancer Chemotherapy and Pharmacology
|
October 9, 2007
Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment
Gerald J Fetterly, Joel S Owen, Kim Stuyckens, et al.
Page
of 2